![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 24859 |
FusionGeneSummary for NRIP1_CSNK1G1 |
![]() |
Fusion gene information | Fusion gene name: NRIP1_CSNK1G1 | Fusion gene ID: 24859 | Hgene | Tgene | Gene symbol | NRIP1 | CSNK1G1 | Gene ID | 8204 | 53944 |
Gene name | nuclear receptor interacting protein 1 | casein kinase 1 gamma 1 | |
Synonyms | RIP140 | CK1gamma1 | |
Cytomap | 21q11.2-q21.1 | 15q22.31 | |
Type of gene | protein-coding | protein-coding | |
Description | nuclear receptor-interacting protein 1nuclear factor RIP140receptor-interacting protein 140 | casein kinase I isoform gamma-1 | |
Modification date | 20180523 | 20180523 | |
UniProtAcc | P48552 | Q9HCP0 | |
Ensembl transtripts involved in fusion gene | ENST00000318948, ENST00000400199, ENST00000400202, | ENST00000303052, ENST00000607537, ENST00000303032, | |
Fusion gene scores | * DoF score | 10 X 3 X 7=210 | 6 X 6 X 6=216 |
# samples | 10 | 6 | |
** MAII score | log2(10/210*10)=-1.0703893278914 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(6/216*10)=-1.84799690655495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: NRIP1 [Title/Abstract] AND CSNK1G1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | NRIP1 | GO:0000122 | negative regulation of transcription by RNA polymerase II | 10364267 |
Hgene | NRIP1 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 7641693|10364267 |
Hgene | NRIP1 | GO:0071392 | cellular response to estradiol stimulus | 15831516 |
Tgene | CSNK1G1 | GO:0018105 | peptidyl-serine phosphorylation | 25500533 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | SARC | TCGA-QC-AA9N-01A | NRIP1 | chr21 | 16415816 | - | CSNK1G1 | chr15 | 64508912 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5UTR-3CDS | ENST00000318948 | ENST00000303052 | NRIP1 | chr21 | 16415816 | - | CSNK1G1 | chr15 | 64508912 | - |
5UTR-3CDS | ENST00000318948 | ENST00000607537 | NRIP1 | chr21 | 16415816 | - | CSNK1G1 | chr15 | 64508912 | - |
5UTR-3CDS | ENST00000318948 | ENST00000303032 | NRIP1 | chr21 | 16415816 | - | CSNK1G1 | chr15 | 64508912 | - |
5UTR-3CDS | ENST00000400199 | ENST00000303052 | NRIP1 | chr21 | 16415816 | - | CSNK1G1 | chr15 | 64508912 | - |
5UTR-3CDS | ENST00000400199 | ENST00000607537 | NRIP1 | chr21 | 16415816 | - | CSNK1G1 | chr15 | 64508912 | - |
5UTR-3CDS | ENST00000400199 | ENST00000303032 | NRIP1 | chr21 | 16415816 | - | CSNK1G1 | chr15 | 64508912 | - |
intron-3CDS | ENST00000400202 | ENST00000303052 | NRIP1 | chr21 | 16415816 | - | CSNK1G1 | chr15 | 64508912 | - |
intron-3CDS | ENST00000400202 | ENST00000607537 | NRIP1 | chr21 | 16415816 | - | CSNK1G1 | chr15 | 64508912 | - |
intron-3CDS | ENST00000400202 | ENST00000303032 | NRIP1 | chr21 | 16415816 | - | CSNK1G1 | chr15 | 64508912 | - |
Top |
FusionProtFeatures for NRIP1_CSNK1G1 |
![]() |
Hgene | Tgene |
NRIP1 | CSNK1G1 |
Modulates transcriptional activation by steroidreceptors such as NR3C1, NR3C2 and ESR1. Also modulatestranscriptional repression by nuclear hormone receptors. Positiveregulator of the circadian clock gene expression: stimulatestranscription of ARNTL/BMAL1, CLOCK and CRY1 by acting as acoactivator for RORA and RORC. {ECO:0000269|PubMed:10364267,ECO:0000269|PubMed:11509661, ECO:0000269|PubMed:11518808,ECO:0000269|PubMed:12554755, ECO:0000269|PubMed:15060175,ECO:0000269|PubMed:21628546, ECO:0000269|PubMed:7641693}. | Serine/threonine-protein kinase. Casein kinases areoperationally defined by their preferential utilization of acidicproteins such as caseins as substrates. It can phosphorylate alarge number of proteins. Participates in Wnt signaling. Regulatesfast synaptic transmission mediated by glutamate (By similarity).Phosphorylates CLSPN. {ECO:0000250, ECO:0000269|PubMed:21680713}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for NRIP1_CSNK1G1 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for NRIP1_CSNK1G1 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
NRIP1 | NR5A1, NR0B1, LDOC1, TEX11, CEP70, CTBP2, TRAF2, CCDC85B, CTBP1, HDAC5, RARA, NR3C1, YWHAQ, RXRA, ESR1, AHR, PPARA, PPARG, THRA, RXRB, JUN, PRMT1, HDAC3, CARM1, XPO1, KPNB1, ESRRA, ESRRB, ESRRG, ESR2, E2F1, ACTN2, CIB1, NR1H2, THRB, RORB, NR1H3, VDR, HNF4A, NR5A2, ELAVL1, CDK8, NR3C2, APP, FHL1, DNMT1, DNMT3A, DNMT3B, PPARGC1A, ARPC3, BRCA1, MAGEA10, HDAC1, HDAC2 | CSNK1G1 | C2orf44, IKZF1, FAM219A, MKRN1, RUNDC3B, APP, PPP1R14A, GCH1, TRAF6, RELA, CEP76, KRTAP10-7, TMEM185A, CSNK1G2, CSNK1G3, PIFO |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for NRIP1_CSNK1G1 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for NRIP1_CSNK1G1 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | NRIP1 | C0014170 | Endometrial Neoplasms | 1 | CTD_human |
Hgene | NRIP1 | C0018801 | Heart failure | 1 | CTD_human |
Hgene | NRIP1 | C0027051 | Myocardial Infarction | 1 | CTD_human |
Hgene | NRIP1 | C0036341 | Schizophrenia | 1 | CTD_human |
Hgene | NRIP1 | C1458155 | Mammary Neoplasms | 1 | CTD_human |